Browser Not Supported

It looks like you're using an outdated browser. To view this site properly, please switch to a more modern browser such as Chrome,Firefox, or Edge.

Dinutuximab

Date last published:

Dinutuximab, also referred to as Chimeric 14.18, is an anti-cancer agent used in the treatment of neuroblastoma.

This document is only valid for the day on which it is accessed. Please read our .
Child cancer
Tools